Federated Hermes
AXSM icon

Federated Hermes’s Axsome Therapeutics AXSM Stock Holding History

Federated Hermes’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.4M Buy
108,571
+21,291
+24% +$3.68M 0.03% 492
2025
Q4 		$15.9M Buy
87,280
+29,995
+52% +$4.19M 0.03% 500
2025
Q3 		$6.96M Buy
57,285
+816
+1% +$91.9K 0.01% 666
2025
Q2 		$5.89M Buy
56,469
+30,479
+117% +$3.23M 0.01% 689
2025
Q1 		$3.03M Buy
+25,990
New +$2.96M 0.01% 837
2020
Q4 		– Sell
-7
Closed -$1K – 2242
2020
Q3 		$1K Sell
7
-20,724
-100% -$1.61M ﹤0.01% 2140
2020
Q2 		$1.71M Sell
20,731
-14,307
-41% -$1.1M ﹤0.01% 1046
2020
Q1 		$2.06M Sell
35,038
-4,287
-11% -$349K 0.01% 888
2019
Q4 		$4.07M Buy
39,325
+26,200
+200% +$1.06M 0.01% 827
2019
Q3 		$266K Buy
+13,125
New +$337K ﹤0.01% 1543

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes's AXSM Position: Q1 2026 in Review

Federated Hermes increased its Axsome Therapeutics (AXSM) stake by 24% in Q1 2026, buying an estimated $3.68M and bringing the position to 108,571 shares worth $18.4M. The position accounts for 0.03% of the portfolio, ranked #492.

Federated Hermes first reported a position in AXSM in Q3 2019 and has held it in 10 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Federated Hermes held 108,571 shares of Axsome Therapeutics worth $18.4M as of Q1 2026.
  • Federated Hermes bought 21,291 Axsome Therapeutics shares in Q1 2026, an estimated $3.68M.
  • Axsome Therapeutics made up 0.03% of Federated Hermes's portfolio in Q1 2026, its #492 holding.
  • Federated Hermes first reported a position in Axsome Therapeutics in Q3 2019 and has held it in 10 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.